Price (90d)
$86.86Signal Score (90d)
100Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $463.06M | $58.16M | $3.18 |
| 2024 | $360.66M | $39.81M | $2.24 |
| 2023 | $325.06M | $38.46M | $2.34 |
| 2022 | $321.23M | $11.64M | $0.65 |
| 2021 | $445.47M | $52.06M | $2.75 |
Social Signal Score
Earnings
Wed, Nov 4(in 3 months)
Consensus estimate $0.33 per share
Typical surprise +21.3% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 4$0.18 vs $0.12beat
- Thu, May 7$0.61 vs $0.60beat
- Mon, Mar 2$0.42 vs $0.87miss
- Wed, Nov 5$1.05 vs $0.81beat
- Wed, Aug 6$0.98 vs $0.79beat
- Wed, May 7$0.91 vs $0.75beat
Estimates and results for TPB via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
Project earnings forward and see what return today's price implies.
Seeded from TPB's reported EPS growth of 3.7% a year over 4 years.
- EPS in 5 years
- $3.81
- Implied price
- $129.49
- Return from $87.34
- 8.2% a year
To earn 15.0% a year on these assumptions you'd need to buy at $64.38 — -26.3% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 24 | 29 | 34 | 39 | 44 |
|---|---|---|---|---|---|
| -6.3% | -8.8% | -5.3% | -2.2% | 0.5% | 2.9% |
| -1.3% | -4.0% | -0.2% | 3.0% | 5.8% | 8.4% |
| 3.7% | 0.9% | 4.8% | 8.2% | 11.2% | 13.9% |
| 8.7% | 5.8% | 9.9% | 13.4% | 16.6% | 19.4% |
| 13.7% | 10.6% | 14.9% | 18.6% | 21.9% | 24.9% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (2)
- Newsfool.com·6d ago·Neutral
Can Turning Point Brands Defend a "Dr. Pepper"‑Size Share After the FDA's Nicotine Pouch Decision? Turning Point Brands now gets over 40% of its sales from fast-growing nicotine pouches. Upcoming earnings will show if TPB can defend a niche share as big tobacco crowds into pouches.
View source ↗ - Newsmarketbeat.com·6d ago·Neutral
Turning Point Brands Q2 Earnings Call Highlights Turning Point Brands NYSE: TPB reported second-quarter 2026 sales growth led by its Modern Oral nicotine pouch business, while increased spending on sales, marketing and retail execution weighed on adjusted EBITDA.
View source ↗